Technology that Supports the Patient Journey and Product Lifecycle
Drug Discovery & Development, Joanne Van Zuidam |
Last month, Lash Group, a part of AmerisourceBergen, launched its new patient support technology ecosystem, Fusion. The platform combines different technologies to deliver an end-to-end solution for manufacturers, providers, and ultimately, patients. In an interview with Drug Discovery & Development, Bill Smith, Senior Vice President, Business Transformation, discussed why they created Fusion and what they hope it will do for the healthcare industry.